全球减肥药物研发格局一览 肥胖一直是公众所密切关注的重要议题,2023世界肥胖图谱(The World Obesity Atlas 2023)显示,如果我们不采取任何行动,那么到2035年,全球超重和肥胖人口将会超过40亿。随着肥胖人口增加以及在胰高血糖样肽-1(GLP-1)类减重药物上的突破,近期产业界减重疗法管线也大幅增长。IQVIA近期对当前全球减肥...
今年3月份,世界肥胖联盟公布的最新版《World Obesity Atlas 2023》预测,到2035年,全球将有超过40亿人属于肥胖或超重,占全球人口的51%。美国2035年成人肥胖率预测将达58%,2020年至2035年的年增长率达到2.1%;中国2035年成人肥胖率预测将达到18%,2020年至2035年的年增长率将达到5.4%。2035年超重/肥胖管理相关费用预...
In the2023 World Obesity Atlas report, the organization projected that 51% of the global population will be "living with overweight and obesity within 12 years if prevention, treatment and support do not improve." If current trends prevail, the report also predicts childhood obesity could more th...
Obesity among children and young people is on course to increase faster than among adults. By 2035 it is expected to be at least double the rate seen in 2020, according to the federation’s latest annual World Obesity Atlas report. 目前,儿童和青年群体中肥胖症患者增速比成年人更快。根据世界肥...
The forum also focused on the prevalence of obesity among the Chinese population and strategies for diagnosis and treatment, showcasing new research in obesity treatment,highlights of the key results of the Chinese translation of...
A new report by the World Obesity Federation (WOF) has said more than half of the world's population will be obese or overweight by 2035 if significant action isn't taken. The federation's 2023 atlas(地图册) also predicted that childhood obesity levels could more than double over the next...
The Coronavirus Pandemic Came and Atlas Shrugged Leaving Against Medical Advice Covid Calculations – It’s Tough Health Injustice At the End of the Rainbow – UV and COVID-19 My Week in Words More COVID-19 Coronavirus Thoughts First Thoughts on Coronavirus From a Primary Care Physician ...
2023 Program Committee Page S4 View PDF INVITED SPEAKERS select article THE ROLE OF ADIPOSE-CARTILAGE CROSSTALK IN OSTEOARTHRITIS Conference abstractOpen archive THE ROLE OF ADIPOSE-CARTILAGE CROSSTALK IN OSTEOARTHRITIS K.H. Collins, E.V. Ely, H.D. Welhaven, A.E. Erdogan, ... F. Guilak Pages...
In the decades-long search for a “silver bullet” to tackle the U.S. obesity crisis, immense sums have been spent on diets, pills, and intensive workout programs. Now, researchers say GLP-1 — originally a treatment for type 2 diabetes — also addresses obesity, effectively solving two ...
2021;21(1):351. Article PubMed PubMed Central Google Scholar Gallagher EJ, LeRoith D. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care. 2013;36 Suppl 2(Suppl 2):S233-9. Article PubMed Google Scholar Download references...